Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aziyo Biologics Inc Cl A (AZYO)

Aziyo Biologics Inc Cl A (AZYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aziyo Biologics Inc Cl A 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 USA

www.aziyobiologics.com P: 240-247-1170

Description:

Aziyo Biologics Inc.is a regenerative medicine company. It focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. The company operates principally in Roswell, Georgia; and Richmond, California. Aziyo Biologics Inc.is based in Silver Spring, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 24,213
Enterprise Value, $K 31,483
Shares Outstanding, K 16,250
Annual Sales, $ 49,190 K
Annual Net Income, $ -32,900 K
Last Quarter Sales, $ 10,300 K
Last Quarter Net Income, $ -10,620 K
EBIT, $ -32,140 K
EBITDA, $ -28,290 K
60-Month Beta -0.09
% of Insider Shareholders 37.10%
% of Institutional Shareholders 18.50%
Float, K 10,221
% Float 62.90%
Short Volume Ratio 0.77

Growth:

1-Year Return -79.62%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.65 on 08/14/23
Latest Earnings Date N/A
Earnings Per Share ttm -2.25
EPS Growth vs. Prev Qtr -32.65%
EPS Growth vs. Prev Year 5.80%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AZYO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -55.92%
Profit Margin % -66.88%
Debt/Equity -1.13
Price/Sales 0.48
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.36
Interest Coverage -5.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar